Annual long term liabilities:
$3.10M-$3.07M(-49.74%)Summary
- As of today (July 1, 2025), CPRX annual total long term liabilities is $3.10 million, with the most recent change of -$3.07 million (-49.74%) on December 31, 2024.
- During the last 3 years, CPRX annual long term liabilities has fallen by -$793.00 thousand (-20.36%).
- CPRX annual long term liabilities is now -82.40% below its all-time high of $17.62 million, reached on December 31, 2022.
Performance
CPRX Long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly long term liabilities:
$2.94M-$161.00K(-5.19%)Summary
- As of today (July 1, 2025), CPRX quarterly total long term liabilities is $2.94 million, with the most recent change of -$161.00 thousand (-5.19%) on March 31, 2025.
- Over the past year, CPRX quarterly long term liabilities has dropped by -$2.76 million (-48.40%).
- CPRX quarterly long term liabilities is now -84.01% below its all-time high of $18.39 million, reached on September 30, 2022.
Performance
CPRX quarterly long term liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CPRX Long term liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -49.7% | -48.4% |
3 y3 years | -20.4% | -22.9% |
5 y5 years | +378.9% | +417.2% |
CPRX Long term liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -82.4% | at low | -84.0% | at low |
5 y | 5-year | -82.4% | >+9999.0% | -84.0% | >+9999.0% |
alltime | all time | -82.4% | >+9999.0% | -84.0% | >+9999.0% |
CPRX Long term liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $2.94M(-5.2%) |
Dec 2024 | $3.10M(-49.7%) | $3.10M(-45.3%) |
Sep 2024 | - | $5.67M(+5.3%) |
Jun 2024 | - | $5.39M(-5.5%) |
Mar 2024 | - | $5.70M(-7.6%) |
Dec 2023 | $6.17M(-65.0%) | $6.17M(-10.0%) |
Sep 2023 | - | $6.86M(-57.4%) |
Jun 2023 | - | $16.10M(-4.5%) |
Mar 2023 | - | $16.86M(-4.3%) |
Dec 2022 | $17.62M(+352.5%) | $17.62M(-4.2%) |
Sep 2022 | - | $18.39M(+393.2%) |
Jun 2022 | - | $3.73M(-2.2%) |
Mar 2022 | - | $3.81M(-2.1%) |
Dec 2021 | $3.89M(>+9900.0%) | $3.89M(-2.0%) |
Sep 2021 | - | $3.97M(-1.9%) |
Jun 2021 | - | $4.05M(-1.9%) |
Mar 2021 | - | $4.13M(>+9900.0%) |
Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2020 | - | $0.00(0.0%) |
Jun 2020 | - | $0.00(-100.0%) |
Mar 2020 | - | $568.40K(-12.2%) |
Dec 2019 | $647.50K(+318.3%) | $647.50K(-10.8%) |
Sep 2019 | - | $725.70K(-9.4%) |
Jun 2019 | - | $801.30K(-8.4%) |
Mar 2019 | - | $875.10K(+465.3%) |
Dec 2018 | $154.80K(-1.7%) | $154.80K(-6.1%) |
Sep 2018 | - | $164.80K(+15.0%) |
Jun 2018 | - | $143.30K(-4.7%) |
Mar 2018 | - | $150.40K(-4.5%) |
Dec 2017 | $157.50K(-48.1%) | $157.50K(-4.3%) |
Sep 2017 | - | $164.50K(-3.5%) |
Jun 2017 | - | $170.50K(-75.5%) |
Mar 2017 | - | $695.50K(+129.2%) |
Dec 2016 | $303.40K | $303.40K(-26.8%) |
Sep 2016 | - | $414.30K(+33.5%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | $310.30K(-33.3%) |
Mar 2016 | - | $465.50K(-60.7%) |
Dec 2015 | $1.18M(-57.9%) | $1.18M(-22.4%) |
Sep 2015 | - | $1.53M(-49.0%) |
Jun 2015 | - | $2.99M(-16.4%) |
Mar 2015 | - | $3.58M(+27.3%) |
Dec 2014 | $2.81M(+52.9%) | $2.81M(-14.4%) |
Sep 2014 | - | $3.28M(+38.1%) |
Jun 2014 | - | $2.38M(+10.3%) |
Mar 2014 | - | $2.15M(+17.2%) |
Dec 2013 | $1.84M(+253.3%) | $1.84M(-48.4%) |
Sep 2013 | - | $3.56M(+235.2%) |
Jun 2013 | - | $1.06M(+88.1%) |
Mar 2013 | - | $565.20K(+8.6%) |
Dec 2012 | $520.50K(-68.5%) | $520.50K(-73.4%) |
Sep 2012 | - | $1.96M(+217.6%) |
Jun 2012 | - | $616.10K(-55.8%) |
Mar 2012 | - | $1.39M(-15.8%) |
Dec 2011 | $1.65M(>+9900.0%) | $1.65M(>+9900.0%) |
Sep 2011 | - | $0.00(0.0%) |
Jun 2011 | - | $0.00(-100.0%) |
Mar 2011 | - | $10.70K(-27.2%) |
Dec 2010 | $14.70K(-73.0%) | $14.70K(-21.8%) |
Sep 2010 | - | $18.80K(-60.3%) |
Jun 2010 | - | $47.40K(+1.3%) |
Mar 2010 | - | $46.80K(-14.0%) |
Dec 2009 | $54.40K(+27.7%) | $54.40K(+9.7%) |
Sep 2009 | - | $49.60K(+36.3%) |
Jun 2009 | - | $36.40K(-7.8%) |
Mar 2009 | - | $39.50K(-7.3%) |
Dec 2008 | $42.60K(-21.0%) | $42.60K(-6.8%) |
Sep 2008 | - | $45.70K(-6.2%) |
Jun 2008 | - | $48.70K(-4.7%) |
Mar 2008 | - | $51.10K(-5.2%) |
Dec 2007 | $53.90K | $53.90K |
FAQ
- What is Catalyst Pharmaceuticals annual total long term liabilities?
- What is the all time high annual long term liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals annual long term liabilities year-on-year change?
- What is Catalyst Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Catalyst Pharmaceuticals?
- What is Catalyst Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Catalyst Pharmaceuticals annual total long term liabilities?
The current annual long term liabilities of CPRX is $3.10M
What is the all time high annual long term liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high annual total long term liabilities is $17.62M
What is Catalyst Pharmaceuticals annual long term liabilities year-on-year change?
Over the past year, CPRX annual total long term liabilities has changed by -$3.07M (-49.74%)
What is Catalyst Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of CPRX is $2.94M
What is the all time high quarterly long term liabilities for Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals all-time high quarterly total long term liabilities is $18.39M
What is Catalyst Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, CPRX quarterly total long term liabilities has changed by -$2.76M (-48.40%)